More than 10,000 cancer researchers, clinicians and patient advocates from across the globe are expected to attend this year’s San Antonio Breast Cancer Symposium, Dec. 10-13.
The meeting will feature presentations by several University of North Carolina-Chapel Hill and UNC Lineberger Comprehensive Cancer Center faculty members and trainees.
Wednesday, Dec. 11
Oral Presentation
2 – 3 p.m. CT | Stars at Night 1-2
Translational Controversies: How to Define Triple Negative Breast Cancer
Presenter: Charles Perou, PhD
Poster Presentation
12:30 – 2 p.m. CT | Halls 2-3
Poster Session 2
P1-02-24: Leveraging bulk and single-cell RNA sequencing to identify features predicting response and survival to abemaciclib in six mouse models of breast cancer
Presenter: Yash Agrawal, MD
P1-11-25: Real-World Data on Adjuvant Abemaciclib in High-Risk Hormone Receptor-Positive Early Breast Cancer: A Retrospective Study
Presenter: Paola Zagami, MD
5:30 – 7:30 p.m. CT | Halls 2-3
Poster Session 2
P2-03-15: Identifying pre-habilitation targets for the mitigation of long-term side effects of chemotherapy in patients with early breast cancer
Presenter: Lyndsay Cooper
Thursday, Dec. 12
Poster Presentation
7 – 8:30 a.m. CT | Hemisfair Ballroom 1-2
Session 2: Personalizing CDK 4/6 inhibitor therapy for patients with Metastatic Breast Cancer: Survival, QOL and biomarkers
Moderator: Lisa Carey, MD, ScM, FASCO
7 – 8:30 a.m. CT | Stars at Night 3-4
Session 9: ctDNA uses for Minimal Residual Disease testing, tumor evolution, and novel technologies
Moderator: Charles Perou, PhD
7:30 –7:45 a.m. CT Evaluating Minimal Residual Disease
Discussant: Yara Abdou, MD
Oral Presentation
9 – 11:45 am. CT | Hall 1
GS2-02: Impact of Tamoxifen Only after Breast Conservation Surgery for “Good Risk” Duct Carcinoma in Situ: Results from the NRG Oncology/RTOG 9804 and ECOG-ACRIN E5194 Trial
Presenter: Jean Wright, MD, FASCO
Poster Presentation
12:30 – 2 p.m. CT | Halls 2-3
Poster Session 3
P3-06-14: Evaluating “Spinning Science” A Patient-Led Health Literacy Educational Program for People Living with Metastatic Breast Cancer
Presenter: Mya Roberson, PhD, MSPH
Clinical Controversies
2 – 3 p.m. CT | Stars at Night 1-2
Omission of Axillary Staging in ER+ Disease Implications for Radiotherapy
Presenter: Jean Wright, MD, FASCO
Educational Session
3:30 – 5:15 p.m. CT | Stars at Night 3-4
Digital Tools for Clinical Practice
Presenter: Emily Ray, MD, MPH
Friday, Dec. 13
Poster Presentation
7 – 8:30 a.m. CT | Hemisfair Ballroom 3
Session 10: Addressing Racial Disparities in Breast Cancer Outcomes
Moderator: Yara Abdou, MD
7 – 8:30 a.m. CT | Room 221ABC
Session 12: Immunobiology Impact on Therapeutic Efficacy
PS12-05: PARP7 inhibition combined with radiotherapy overcomes ICI resistance in breast cancer
Presenter: Lynn Lerner
Oral Presentation
9 – 11:45 a.m. CT | Hall 1
General Session 3
GS3-10: Paired DNA and RNA analysis of CALGB 40603 (Alliance) reveals insights into the molecular and prognostic landscape of stage II-III triple-negative breast cancer
Presenter: Brooke Felsheim
Poster Presentation
12:30 – 2 p.m. CT | Halls 2-3
Poster Session 5
P5-02-08: Assessing Medical Mistrust among Black Adults with and without a Family History of Breast Cancer
Presenter: Mya Roberson, PhD, MSPH
P5-12-21: The utility of antiestrogen therapy in early-stage, pure mucinous carcinomas of the breast
Presenter: Lyndsay Cooper